Home › Funds › GREAT POINT PARTNERS LLC › EVMN

GREAT POINT PARTNERS LLC position in EVMN

EVOMMUNE INC · Health Care

GREAT POINT PARTNERS LLC reported holding 325,000 shares of EVMN (EVOMMUNE INC) in its Q2 2026 13F filing — a position valued at US$4.3M, representing 0.91% of its reported portfolio and ranking #33 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed EVMN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)325.00K sh
Reported value held$4.32M
Portfolio Weight0.91%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's EVMN position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in EVMN in Q4 2025 at 325,000 shares (US$5.6M). The position peaked in Q1 2026 at 325,000 shares, worth US$7.5M. Across 3 filings, GREAT POINT PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 325,000 shares valued at US$4.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 325.00K $5.56M New
Q1 2026 325.00K $7.47M Hold
Q2 2026 325.00K $4.32M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EVMN and 13F data

EVMN (EVOMMUNE INC) is a Health Care company. 116 other funds we track also report a position in EVMN — the largest reported positions include EQT Fund Management S.a r.l. (US$70.3M), RA CAPITAL MANAGEMENT, L.P. (US$46.4M), SymBiosis Capital Partners, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EVMN

All EVMN fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held EVMN?

GREAT POINT PARTNERS LLC has disclosed EVMN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is GREAT POINT PARTNERS LLC's current position in EVMN?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 325.00K shares of EVMN (EVOMMUNE INC), valued at $4.32M, representing 0.91% of its reported portfolio and ranking #33.

Has GREAT POINT PARTNERS LLC been buying or selling EVMN?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC held unchanged its position in EVMN. The position peaked in Q1 2026 at 325.00K shares.

Which other funds hold EVMN?

Other major institutional holders of EVMN include EQT Fund Management S.a r.l., RA CAPITAL MANAGEMENT, L.P., SymBiosis Capital Partners, LLC, among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.